Extra cost of subcutaneous apomorphine would pay for personal nurses

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7158.602a (Published 29 August 1998) Cite this as: BMJ 1998;317:602
  1. Ian Hill-Smith, General practice tutor
  1. Stopsley Group Practice, Wigmore Lane Health Centre, Luton, Bedfordshire LU2 8BG

    EDITOR —In their editorial Chaudhuri and Clough advocate a greater use of subcutaneous apomorphine in patients with Parkinson's disease and point out that a prefilled variable dose pen injector has recently become available.1 My local pharmacist informed me of the increase in cost when a …

    View Full Text

    Sign in

    Log in through your institution